Goldman Sachs Reiterates Neutral Rating on Blue Owl Capital Inc. (OWL)
Rating Change Goldman Sachs analysts reiterated a Neutral rating on Blue Owl Capital Inc. (NYSE:OWL) on August 03, 2026. Market Context Blue Owl Capital Inc.
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change Goldman Sachs analysts reiterated a Neutral rating on Blue Owl Capital Inc. (NYSE:OWL) on August 03, 2026. Market Context Blue Owl Capital Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on MicroStrategy Incorporated (NASDAQ:STRK) on August 03, 2026. Market Context MicroStrategy Incorporated operates…
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on MicroStrategy Incorporated (NASDAQ:STRK) on August 03, 2026. Market Context MicroStrategy Incorporated…
Read moreRating Change B. Riley Securities analysts reiterated a Buy rating on MicroStrategy Incorporated (NASDAQ:STRK) on August 03, 2026. Market Context MicroStrategy Incorporated…
Read moreRating Change Citigroup analysts reiterated a Neutral rating on Biogen Inc. (NASDAQ:BIIB) on August 03, 2026. Market Context Biogen Inc.
Read moreRating Change Guggenheim analysts reiterated a Buy rating on First Solar, Inc. (NASDAQ:FSLR) on August 03, 2026. Market Context First Solar, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on First Solar, Inc. (NASDAQ:FSLR) on August 03, 2026. Market Context First Solar, Inc.
Read moreRating Change Wells Fargo analysts downgraded eBay Inc. (NASDAQ:EBAY) from Equal-Weight to Underweight on August 03, 2026. Market Context eBay Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Coca-Cola Europacific Partners PLC (NASDAQ:CCEP) on August 03, 2026. Market Context Coca-Cola Europacific…
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Ovid Therapeutics Inc. (NASDAQ:OVID) on August 03, 2026. Market Context Ovid Therapeutics Inc.
Read moreRating Change Piper Sandler analysts initiated coverage on Nebius Group N.V. (NASDAQ:NBIS) with a Neutral rating on August 03, 2026. Market Context Nebius Group N.V.
Read moreRating Change Barclays analysts reiterated a Underweight rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on August 03, 2026.
Read moreRating Change BMO Capital analysts reiterated a Market Perform rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on August 03, 2026.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on August 03, 2026.
Read moreRating Change TD Cowen analysts reiterated a Hold rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on August 03, 2026.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on T. Rowe Price Group, Inc. (NASDAQ:TROW) on August 03, 2026.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Robinhood Markets, Inc. (NASDAQ:HOOD) on August 03, 2026. Market Context Robinhood Markets, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on HCA Healthcare, Inc. (NYSE:HCA) on August 03, 2026. Market Context HCA Healthcare, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Welltower Inc. (NYSE:WELL) on August 03, 2026. Market Context Welltower Inc.
Read moreRating Change BMO Capital analysts reiterated a Outperform rating on KKR & Co. Inc. (NYSE:KKR) on August 03, 2026.
Read more